TSA-1 Polyclonal Antibody

LY6E (Lymphocyte Antigen 6 Complex, Locus E) is a Protein Coding gene. Diseases associated with LY6E include leukemia, acute promyelocytic, somatic and subvalvular aortic stenosis.

The TSA-1 Polyclonal Antibody is a highly specific and sensitive antibody that has been developed for use in a variety of research applications. This antibody has been extensively validated for use in Western blotting, immunohistochemistry, and immunofluorescence assays, and has been shown to exhibit excellent performance in each of these applications.

The TSA-1 Polyclonal Antibody is produced using state-of-the-art techniques and is highly purified to ensure maximum specificity and sensitivity. This antibody is raised against a synthetic peptide corresponding to a region of the TSA-1 protein, and has been shown to exhibit high affinity for this target.

This antibody is suitable for use in a wide range of research applications, including studies of protein expression, localization, and function. It is particularly useful for studies of the TSA-1 protein, which has been implicated in a variety of cellular processes, including cell growth, differentiation, and apoptosis.

Overall, the TSA-1 Polyclonal Antibody is a highly reliable and effective tool for researchers working in a variety of fields, and is an excellent choice for those looking to study the function and regulation of the TSA-1 protein.